Regulatory Affairs Market Size, Share & Trends Analysis Report By Services, By End-use, By Category, By Indication, By Product Stage, By Service Provider, By Company Size, By Region, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 1 Business Day
Regulatory Affairs Market Growth & Trends
The global regulatory affairs market size is expected to reach USD 27.0 billion by 2030, registering a CAGR of 8.7% over the forecast years, according to a new report by Grand View Research, Inc. The factors expected to contribute to the growth of this market include changing regulatory requirements based on business activities and geographies, an increase in clinical trials & drug approvals along with accelerated regulatory approval, and technological advancement in regulatory software. Also, the evolution of personalized medicines, the increasing need for companies to focus on core business activities, and economic and competitive pressures are other factors that are contributing to the growth of the market. The global market showed lucrative growth during the COVID-19 pandemic.
The pharmaceutical and regulatory agencies joined forces to rapidly develop vaccines and medical products required to fight against COVID-19. The regulatory authorities take numerous precautions to ensure patient and personnel safety during a clinical trial, as well as data integrity and good laboratory practices, are maintained. Growth in markets for biosimilars, orphan drugs, personalized medicines, companion diagnostics, and adaptive trial designs are projected to boost the demand for regulatory specialization in these areas. As companies venture into newer fields, the growing need to comply with regulations is boosting the demand for specialized service providers with expertise in regulatory affairs. Patent expiration of biologics, such as Simulect, Vectibix, Mircera, and Kineret, is increasing the demand and development of biosimilars, thereby contributing to the demand for regulatory services in this segment.
Regulatory Affairs Market Report Highlights
Regulatory Affairs Market Growth & Trends
The global regulatory affairs market size is expected to reach USD 27.0 billion by 2030, registering a CAGR of 8.7% over the forecast years, according to a new report by Grand View Research, Inc. The factors expected to contribute to the growth of this market include changing regulatory requirements based on business activities and geographies, an increase in clinical trials & drug approvals along with accelerated regulatory approval, and technological advancement in regulatory software. Also, the evolution of personalized medicines, the increasing need for companies to focus on core business activities, and economic and competitive pressures are other factors that are contributing to the growth of the market. The global market showed lucrative growth during the COVID-19 pandemic.
The pharmaceutical and regulatory agencies joined forces to rapidly develop vaccines and medical products required to fight against COVID-19. The regulatory authorities take numerous precautions to ensure patient and personnel safety during a clinical trial, as well as data integrity and good laboratory practices, are maintained. Growth in markets for biosimilars, orphan drugs, personalized medicines, companion diagnostics, and adaptive trial designs are projected to boost the demand for regulatory specialization in these areas. As companies venture into newer fields, the growing need to comply with regulations is boosting the demand for specialized service providers with expertise in regulatory affairs. Patent expiration of biologics, such as Simulect, Vectibix, Mircera, and Kineret, is increasing the demand and development of biosimilars, thereby contributing to the demand for regulatory services in this segment.
Regulatory Affairs Market Report Highlights
- The regulatory writing & publishing segment dominated the market in 2021 due to an increase in the outsourcing of these services by large- and mid-size medical device and biopharmaceutical companies
- Based on indications, the oncology segment accounted for the largest revenue share in 2021. The segment share is attributed to the high prevalence of cancer, which is creating the need for safe and effective treatments
- Based on end-uses, the pharmaceutical companies segment accounted for the largest market share in 2021. A rise in the number of approved pharmaceutical products is the key factor responsible for the segment’s growth
- Asia Pacific is projected to witness the fastest growth rate during the forecast period on account of the improved regulatory landscape and growing venture activities by biopharmaceutical companies
CHAPTER 1 METHODOLOGY AND SCOPE
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Region Wise Market Calculation
1.6.1 Region Wise Market: Base Estimates
1.6.2 Global Market: CAGR Calculation
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective -
1.9.2 Objective -
1.9.3 Objective -
1.9.4 Objective -
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
CHAPTER 3 REGULATORY AFFAIRS MARKET: VARIABLES, TRENDS, & SCOPE
3.1 Market Segmentation and Scope
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Changing regulatory landscape
3.2.1.2 Entry of companies into the global market
3.2.1.3 Life science companies focusing on their core competencies
3.2.1.4 Economic and competitive pressures
3.2.1.5 Demand for the faster approval process for breakthrough drugs and devices
3.2.1.6 Growth in emerging areas such as personalized medicine, biosimilars, and orphan drugs
3.2.2 Market Restraint Analysis
3.2.2.1 Risk associated with data security
3.2.2.2 Monitoring issues and lack of standardization
3.3 Penetration & Growth Prospect Mapping
3.4 Industry Challenges
3.4.1 Managing Relationship
3.5 Major Deals and Strategic Alliances Analysis
3.6 Major Deals and Strategic Alliances Analysis (Biotech & ATMPs)
3.7 Regulatory affairs: Market Analysis Tools
3.7.1 SWOT
3.7.2 Industry Analysis - Porter’s
3.7.3 PESTEL Analysis
3.8 COVID- 19 Impact Analysis
CHAPTER 4 REGULATORY AFFAIRS MARKET: SERVICE SEGMENT ANALYSIS
4.1 Regulatory affairs: Service Market Share Analysis, 2021 & 2030
4.2 Regulatory Consulting
4.2.1 Regulatory consulting market, 2018 - 2030 (USD Million)
4.3 Legal Representation
4.3.1 Legal representation market, 2018 - 2030 (USD Million)
4.4 Regulatory Writing and Publishing
4.4.1 Regulatory writing and publishing market, 2018 - 2030 (USD Million)
4.4.2 Writing market, 2018 - 2030 (USD Million)
4.4.3 Publishing market, 2018 - 2030 (USD Million)
4.5 Product Registration and Clinical Trial Application
4.5.1 Product registration and clinical trial application market, 2018 - 2030 (USD Million)
4.6 Other Regulatory Services
4.6.1 Other regulatory services market, 2018 - 2030 (USD Million)
CHAPTER 5 REGULATORY AFFAIRS MARKET: SERVICE PROVIDER SEGMENT ANALYSIS
5.1 Regulatory Affairs: Service Provider Market Share Analysis, 2021 & 2030
5.2 In-house
5.2.1 In-house regulatory affairs market, 2018 - 2030 (USD Million)
5.3 Outsourcing
5.3.1 outsourcing market, 2018 - 2030 (USD Million)
CHAPTER 6 REGULATORY AFFAIRS MARKET: COMPANY SIZE SEGMENT ANALYSIS
6.1 Regulatory Affairs: Company Size Market Share Analysis, 2021 & 2030
6.2 Smalls-ized
6.2.1 Small companies based regulatory affairs market, 2018 - 2030 (USD Million)
6.3 Medium-sized
6.3.1 Medium-sized companies based on regulatory affairs market, 2018 - 2030 (USD Million)
6.4 Large Companies
6.4.1 large companies based on regulatory affairs market, 2018 - 2030 (USD Million)
CHAPTER 7 REGULATORY AFFAIRS MARKET: CATEGORIES SEGMENT ANALYSIS
7.1 Regulatory Affairs: Categories Market Share Analysis, 2021 & 2030
7.2 Drugs
7.2.1 drugs based regulatory affairs market, 2018 - 2030 (USD Million)
7.3 Biologics
7.3.1 Biologics-based regulatory affairs market, 2018 - 2030 (USD Million)
7.4 Medical Devices
7.4.1 medical devices based regulatory affairs market, 2018 - 2030 (USD Million)
CHAPTER 8 REGULATORY AFFAIRS MARKET: PRODUCT STAGE SEGMENT ANALYSIS
8.1 Regulatory Affairs: Product Stage Market Share Analysis, 2021 & 2030
8.2 Preclinical
8.2.1 Preclinical-based regulatory affairs market, 2018 - 2030 (USD Million)
8.3 Clinical
8.3.1 Clinical-based regulatory affairs market, 2018 - 2030 (USD Million)
8.4 PMA
8.4.1 PMA-based regulatory affairs market, 2018 - 2030 (USD Million)
CHAPTER 9 REGULATORY AFFAIRS MARKET: INDICATION SEGMENT ANALYSIS
9.1 Regulatory affairs: Indication Market Share Analysis, 2021 & 2030
9.2 Oncology
9.2.1 Oncology-based regulatory affairs market, 2018 - 2030 (USD Million)
9.3 Neurology
9.3.1 Neurology-based regulatory affairs market, 2018 - 2030 (USD Million)
9.4 Cardiology
9.4.1 Cardiology-based regulatory affairs market, 2018 - 2030 (USD Million)
9.5 Immunology
9.5.1 Immunology indication-based regulatory affairs market, 2018 - 2030 (USD Million)
9.6 Other Indications
9.6.1 Other indication-based regulatory affairs market, 2018 - 2030 (USD Million)
CHAPTER 10 REGULATORY AFFAIRS MARKET: END-USE SEGMENT ANALYSIS
10.1 Regulatory affairs: End-use Market Share Analysis, 2021 & 2030
10.2 Medical Device Companies
10.2.1 Medical Device Companies market, 2018 - 2030 (USD Million)
10.3 Pharmaceutical Companies
10.3.1 Pharmaceutical Companies market, 2018 - 2030 (USD Million)
10.4 Biotechnology Companies
10.4.1 Biotechnology Companies market, 2018 - 2030 (USD Million)
CHAPTER 11 REGULATORY AFFAIRS MARKET: REGIONAL ANALYSIS
11.1 Regulatory affairs: Regional Market Share Analysis, 2021 & 2030
11.2 North America
11.2.1 North America Regulatory affairs MARKET, 2018 - 2030 (USD Million)
11.2.2 U.S.
11.2.2.1 U.S. regulatory affairs market, 2018 - 2030 (USD Million)
11.2.3 Canada
11.2.3.1 Canada regulatory affairs market, 2018 - 2030 (USD Million)
11.3 Europe
11.3.1 Europe Regulatory affairs MARKET, 2018 - 2030 (USD Million)
11.3.2 U.K.
11.3.2.1 U.K. regulatory affairs market, 2018 - 2030 (USD Million)
11.3.3 Germany
11.3.3.1 Germany regulatory affairs market, 2018 - 2030 (USD Million)
11.3.4 France
11.3.4.1 France regulatory affairs market, 2018 - 2030 (USD Million)
11.3.5 Italy
11.3.5.1 Italy regulatory affairs market, 2018 - 2030 (USD Million)
11.3.6 Spain
11.3.6.1 Spain regulatory affairs market, 2018 - 2030 (USD Million)
11.3.7 Russia
11.3.7.1 Russia regulatory affairs market, 2018 - 2030 (USD Million)
11.3.8 Turkey
11.3.8.1 Turkey regulatory affairs market, 2018 - 2030 (USD Million)
11.3.9 The Netherlands
11.3.9.1 The Netherlands regulatory affairs market, 2018 - 2030 (USD Million)
11.3.10 Switzerland
11.3.10.1 Switzerland regulatory affairs market, 2018 - 2030 (USD Million)
11.3.11 Sweden
11.3.11.1 Sweden regulatory affairs market, 2018 - 2030 (USD Million)
11.4 Asia Pacific
11.4.1 Asia Pacific Regulatory affairs MARKET, 2018 - 2030 (USD Million)
11.4.2 Japan
11.4.2.1 Japan regulatory affairs market, 2018 - 2030 (USD Million)
11.4.3 China
11.4.3.1 China regulatory affairs market, 2018 - 2030 (USD Million)
11.4.4 India
11.4.4.1 India regulatory affairs market, 2018 - 2030 (USD Million)
11.4.5 Australia
11.4.5.1 Australia regulatory affairs market, 2018 - 2030 (USD Million)
11.4.6 South Korea
11.4.6.1 South Korea regulatory affairs market, 2018 - 2030 (USD Million)
11.4.7 Indonesia
11.4.7.1 Indonesia regulatory affairs market, 2018 - 2030 (USD Million)
11.4.8 Malaysia
11.4.8.1 Malaysia regulatory affairs market, 2018 - 2030 (USD Million)
11.4.9 Singapore
11.4.9.1 Singapore regulatory affairs market, 2018 - 2030 (USD Million)
11.4.10 Thailand
11.4.10.1 Thailand regulatory affairs market, 2018 - 2030 (USD Million)
11.4.11 Taiwan
11.4.11.1 Taiwan regulatory affairs market, 2018 - 2030 (USD Million)
11.5 Latin America
11.5.1 Latin America Regulatory affairs MARKET, 2018 - 2030 (USD Million)
11.5.2 Brazil
11.5.2.1 Brazil regulatory affairs market, 2018 - 2030 (USD Million)
11.5.3 Mexico
11.5.3.1 Mexico regulatory affairs market, 2018 - 2030 (USD Million)
11.5.4 Argentina
11.5.4.1 Argentina regulatory affairs market, 2018 - 2030 (USD Million)
11.5.5 Colombia
11.5.5.1 Colombia regulatory affairs market, 2018 - 2030 (USD Million)
11.5.6 Chile
11.5.6.1 Chile regulatory affairs market, 2018 - 2030 (USD Million)
11.6 MEA
11.6.1 MEA Regulatory affairs MARKET, 2018 - 2030 (USD Million)
11.6.2 South Africa
11.6.2.1 South Africa regulatory affairs market, 2018 - 2030 (USD Million)
11.6.3 Saudi Arabia
11.6.3.1 Saudi Arabia regulatory affairs market, 2018 - 2030 (USD Million)
11.6.4 UAE
11.6.4.1 UAE regulatory affairs market, 2018 - 2030 (USD Million)
11.6.5 Egypt
11.6.5.1 Egypt regulatory affairs market, 2018 - 2030 (USD Million)
11.6.6 Israel
11.6.6.1 Israel regulatory affairs market, 2018 - 2030 (USD Million)
CHAPTER 12 COMPANY PROFILES
12.1 Accell Clinical Research, LLC.
12.1.1 Company overview
12.1.2 Organization structure & Team Composition
12.1.3 Team Composition
12.1.4 Service Benchmarking
12.1.5 Geographic Presence
12.1.6 Strategic Intiatives
12.1.7 SWOT
12.2 GenPact Ltd.
12.2.1 Company overview
12.2.2 Financial performance
12.2.3 Organization structure & Team Composition
12.2.4 Team Composition
12.2.5 Service Benchmarking
12.2.6 Geographic Presence
12.2.7 Strategic initiatives
12.2.8 swot
12.3 Criterium, Inc.
12.3.1 Company overview
12.3.2 Financial performance
12.3.3 Organization structure & Team Composition
12.3.4 Team Composition
12.3.5 Service Benchmarking
12.3.6 Geographic Presence
12.3.7 swot
12.4 PRA Health Sciences
12.4.1 Company overview
12.4.2 Financial Performance
12.4.3 Organization structure & Team Composition
12.4.4 Team Composition
12.4.5 Service Benchmarking
12.4.6 Geographic Presence
12.4.7 Strategic initiatives
12.4.8 SWOT
12.5 Promedica International
12.5.1 Company overview
12.5.2 Financial Performance
12.5.3 Organization structure & Team Composition
12.5.4 Team Composition
12.5.5 Service Benchmarking
12.5.6 Geographic Presence
12.5.7 SWOT
12.6 WuXi AppTec, Inc.
12.6.1 Company overview
12.6.2 Financial performance
12.6.3 Organization structure & Team Composition
12.6.4 Team Composition
12.6.5 Service Benchmarking
12.6.6 Geographic Presence
12.6.7 Strategic initiatives
12.6.8 SWOT
12.7 Medpace
12.7.1 Company overview
12.7.2 Financial performance
12.7.3 Organization structure & Team Composition
12.7.4 Team Composition
12.7.5 Service Benchmarking
12.7.6 Geographic Presence
12.7.7 swot
12.8 Charles River Laboratories International, Inc.
12.8.1 Company overview
12.8.2 Financial performance
12.8.3 Organization structure & Team Composition
12.8.4 Team Composition
12.8.5 Service Benchmarking
12.8.6 Geographic Presence
12.8.7 Strategic initiatives
12.8.8 SWOT
12.9 ICON plc
12.9.1 Company overview
12.9.2 Financial performance
12.9.3 Organization structure & Team Composition
12.9.4 Team Composition
12.9.5 Service Benchmarking
12.9.6 Geographic Presence
12.9.7 Strategic initiatives
12.9.8 SWOT
12.10 Covance
12.10.1 Company overview
12.10.2 Financial performance
12.10.3 Organization structure & Team Composition
12.10.4 Team Composition
12.10.5 Service Benchmarking
12.10.6 Geographic Presence
12.10.7 Strategic initiatives
12.10.8 SWOT
12.11 PAREXEL International Corporation, Inc.
12.11.1 Company overview
12.11.2 Financial performance
12.11.3 Organization structure & Team Composition
12.11.4 Team Composition
12.11.5 Service Benchmarking
12.11.6 Geographic Presence
12.11.7 Strategic initiatives
12.11.8 SWOT
12.12 Freyr
12.12.1 Company overview
12.12.2 Organization structure & Team Composition
12.12.3 Team Composition
12.12.4 Service Benchmarking
12.12.5 Geographic Presence
12.12.6 Strategic initiatives
12.12.7 SWOT
1.1 Market Segmentation & Scope
1.1.1 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Region Wise Market Calculation
1.6.1 Region Wise Market: Base Estimates
1.6.2 Global Market: CAGR Calculation
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective -
1.9.2 Objective -
1.9.3 Objective -
1.9.4 Objective -
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
CHAPTER 3 REGULATORY AFFAIRS MARKET: VARIABLES, TRENDS, & SCOPE
3.1 Market Segmentation and Scope
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Changing regulatory landscape
3.2.1.2 Entry of companies into the global market
3.2.1.3 Life science companies focusing on their core competencies
3.2.1.4 Economic and competitive pressures
3.2.1.5 Demand for the faster approval process for breakthrough drugs and devices
3.2.1.6 Growth in emerging areas such as personalized medicine, biosimilars, and orphan drugs
3.2.2 Market Restraint Analysis
3.2.2.1 Risk associated with data security
3.2.2.2 Monitoring issues and lack of standardization
3.3 Penetration & Growth Prospect Mapping
3.4 Industry Challenges
3.4.1 Managing Relationship
3.5 Major Deals and Strategic Alliances Analysis
3.6 Major Deals and Strategic Alliances Analysis (Biotech & ATMPs)
3.7 Regulatory affairs: Market Analysis Tools
3.7.1 SWOT
3.7.2 Industry Analysis - Porter’s
3.7.3 PESTEL Analysis
3.8 COVID- 19 Impact Analysis
CHAPTER 4 REGULATORY AFFAIRS MARKET: SERVICE SEGMENT ANALYSIS
4.1 Regulatory affairs: Service Market Share Analysis, 2021 & 2030
4.2 Regulatory Consulting
4.2.1 Regulatory consulting market, 2018 - 2030 (USD Million)
4.3 Legal Representation
4.3.1 Legal representation market, 2018 - 2030 (USD Million)
4.4 Regulatory Writing and Publishing
4.4.1 Regulatory writing and publishing market, 2018 - 2030 (USD Million)
4.4.2 Writing market, 2018 - 2030 (USD Million)
4.4.3 Publishing market, 2018 - 2030 (USD Million)
4.5 Product Registration and Clinical Trial Application
4.5.1 Product registration and clinical trial application market, 2018 - 2030 (USD Million)
4.6 Other Regulatory Services
4.6.1 Other regulatory services market, 2018 - 2030 (USD Million)
CHAPTER 5 REGULATORY AFFAIRS MARKET: SERVICE PROVIDER SEGMENT ANALYSIS
5.1 Regulatory Affairs: Service Provider Market Share Analysis, 2021 & 2030
5.2 In-house
5.2.1 In-house regulatory affairs market, 2018 - 2030 (USD Million)
5.3 Outsourcing
5.3.1 outsourcing market, 2018 - 2030 (USD Million)
CHAPTER 6 REGULATORY AFFAIRS MARKET: COMPANY SIZE SEGMENT ANALYSIS
6.1 Regulatory Affairs: Company Size Market Share Analysis, 2021 & 2030
6.2 Smalls-ized
6.2.1 Small companies based regulatory affairs market, 2018 - 2030 (USD Million)
6.3 Medium-sized
6.3.1 Medium-sized companies based on regulatory affairs market, 2018 - 2030 (USD Million)
6.4 Large Companies
6.4.1 large companies based on regulatory affairs market, 2018 - 2030 (USD Million)
CHAPTER 7 REGULATORY AFFAIRS MARKET: CATEGORIES SEGMENT ANALYSIS
7.1 Regulatory Affairs: Categories Market Share Analysis, 2021 & 2030
7.2 Drugs
7.2.1 drugs based regulatory affairs market, 2018 - 2030 (USD Million)
7.3 Biologics
7.3.1 Biologics-based regulatory affairs market, 2018 - 2030 (USD Million)
7.4 Medical Devices
7.4.1 medical devices based regulatory affairs market, 2018 - 2030 (USD Million)
CHAPTER 8 REGULATORY AFFAIRS MARKET: PRODUCT STAGE SEGMENT ANALYSIS
8.1 Regulatory Affairs: Product Stage Market Share Analysis, 2021 & 2030
8.2 Preclinical
8.2.1 Preclinical-based regulatory affairs market, 2018 - 2030 (USD Million)
8.3 Clinical
8.3.1 Clinical-based regulatory affairs market, 2018 - 2030 (USD Million)
8.4 PMA
8.4.1 PMA-based regulatory affairs market, 2018 - 2030 (USD Million)
CHAPTER 9 REGULATORY AFFAIRS MARKET: INDICATION SEGMENT ANALYSIS
9.1 Regulatory affairs: Indication Market Share Analysis, 2021 & 2030
9.2 Oncology
9.2.1 Oncology-based regulatory affairs market, 2018 - 2030 (USD Million)
9.3 Neurology
9.3.1 Neurology-based regulatory affairs market, 2018 - 2030 (USD Million)
9.4 Cardiology
9.4.1 Cardiology-based regulatory affairs market, 2018 - 2030 (USD Million)
9.5 Immunology
9.5.1 Immunology indication-based regulatory affairs market, 2018 - 2030 (USD Million)
9.6 Other Indications
9.6.1 Other indication-based regulatory affairs market, 2018 - 2030 (USD Million)
CHAPTER 10 REGULATORY AFFAIRS MARKET: END-USE SEGMENT ANALYSIS
10.1 Regulatory affairs: End-use Market Share Analysis, 2021 & 2030
10.2 Medical Device Companies
10.2.1 Medical Device Companies market, 2018 - 2030 (USD Million)
10.3 Pharmaceutical Companies
10.3.1 Pharmaceutical Companies market, 2018 - 2030 (USD Million)
10.4 Biotechnology Companies
10.4.1 Biotechnology Companies market, 2018 - 2030 (USD Million)
CHAPTER 11 REGULATORY AFFAIRS MARKET: REGIONAL ANALYSIS
11.1 Regulatory affairs: Regional Market Share Analysis, 2021 & 2030
11.2 North America
11.2.1 North America Regulatory affairs MARKET, 2018 - 2030 (USD Million)
11.2.2 U.S.
11.2.2.1 U.S. regulatory affairs market, 2018 - 2030 (USD Million)
11.2.3 Canada
11.2.3.1 Canada regulatory affairs market, 2018 - 2030 (USD Million)
11.3 Europe
11.3.1 Europe Regulatory affairs MARKET, 2018 - 2030 (USD Million)
11.3.2 U.K.
11.3.2.1 U.K. regulatory affairs market, 2018 - 2030 (USD Million)
11.3.3 Germany
11.3.3.1 Germany regulatory affairs market, 2018 - 2030 (USD Million)
11.3.4 France
11.3.4.1 France regulatory affairs market, 2018 - 2030 (USD Million)
11.3.5 Italy
11.3.5.1 Italy regulatory affairs market, 2018 - 2030 (USD Million)
11.3.6 Spain
11.3.6.1 Spain regulatory affairs market, 2018 - 2030 (USD Million)
11.3.7 Russia
11.3.7.1 Russia regulatory affairs market, 2018 - 2030 (USD Million)
11.3.8 Turkey
11.3.8.1 Turkey regulatory affairs market, 2018 - 2030 (USD Million)
11.3.9 The Netherlands
11.3.9.1 The Netherlands regulatory affairs market, 2018 - 2030 (USD Million)
11.3.10 Switzerland
11.3.10.1 Switzerland regulatory affairs market, 2018 - 2030 (USD Million)
11.3.11 Sweden
11.3.11.1 Sweden regulatory affairs market, 2018 - 2030 (USD Million)
11.4 Asia Pacific
11.4.1 Asia Pacific Regulatory affairs MARKET, 2018 - 2030 (USD Million)
11.4.2 Japan
11.4.2.1 Japan regulatory affairs market, 2018 - 2030 (USD Million)
11.4.3 China
11.4.3.1 China regulatory affairs market, 2018 - 2030 (USD Million)
11.4.4 India
11.4.4.1 India regulatory affairs market, 2018 - 2030 (USD Million)
11.4.5 Australia
11.4.5.1 Australia regulatory affairs market, 2018 - 2030 (USD Million)
11.4.6 South Korea
11.4.6.1 South Korea regulatory affairs market, 2018 - 2030 (USD Million)
11.4.7 Indonesia
11.4.7.1 Indonesia regulatory affairs market, 2018 - 2030 (USD Million)
11.4.8 Malaysia
11.4.8.1 Malaysia regulatory affairs market, 2018 - 2030 (USD Million)
11.4.9 Singapore
11.4.9.1 Singapore regulatory affairs market, 2018 - 2030 (USD Million)
11.4.10 Thailand
11.4.10.1 Thailand regulatory affairs market, 2018 - 2030 (USD Million)
11.4.11 Taiwan
11.4.11.1 Taiwan regulatory affairs market, 2018 - 2030 (USD Million)
11.5 Latin America
11.5.1 Latin America Regulatory affairs MARKET, 2018 - 2030 (USD Million)
11.5.2 Brazil
11.5.2.1 Brazil regulatory affairs market, 2018 - 2030 (USD Million)
11.5.3 Mexico
11.5.3.1 Mexico regulatory affairs market, 2018 - 2030 (USD Million)
11.5.4 Argentina
11.5.4.1 Argentina regulatory affairs market, 2018 - 2030 (USD Million)
11.5.5 Colombia
11.5.5.1 Colombia regulatory affairs market, 2018 - 2030 (USD Million)
11.5.6 Chile
11.5.6.1 Chile regulatory affairs market, 2018 - 2030 (USD Million)
11.6 MEA
11.6.1 MEA Regulatory affairs MARKET, 2018 - 2030 (USD Million)
11.6.2 South Africa
11.6.2.1 South Africa regulatory affairs market, 2018 - 2030 (USD Million)
11.6.3 Saudi Arabia
11.6.3.1 Saudi Arabia regulatory affairs market, 2018 - 2030 (USD Million)
11.6.4 UAE
11.6.4.1 UAE regulatory affairs market, 2018 - 2030 (USD Million)
11.6.5 Egypt
11.6.5.1 Egypt regulatory affairs market, 2018 - 2030 (USD Million)
11.6.6 Israel
11.6.6.1 Israel regulatory affairs market, 2018 - 2030 (USD Million)
CHAPTER 12 COMPANY PROFILES
12.1 Accell Clinical Research, LLC.
12.1.1 Company overview
12.1.2 Organization structure & Team Composition
12.1.3 Team Composition
12.1.4 Service Benchmarking
12.1.5 Geographic Presence
12.1.6 Strategic Intiatives
12.1.7 SWOT
12.2 GenPact Ltd.
12.2.1 Company overview
12.2.2 Financial performance
12.2.3 Organization structure & Team Composition
12.2.4 Team Composition
12.2.5 Service Benchmarking
12.2.6 Geographic Presence
12.2.7 Strategic initiatives
12.2.8 swot
12.3 Criterium, Inc.
12.3.1 Company overview
12.3.2 Financial performance
12.3.3 Organization structure & Team Composition
12.3.4 Team Composition
12.3.5 Service Benchmarking
12.3.6 Geographic Presence
12.3.7 swot
12.4 PRA Health Sciences
12.4.1 Company overview
12.4.2 Financial Performance
12.4.3 Organization structure & Team Composition
12.4.4 Team Composition
12.4.5 Service Benchmarking
12.4.6 Geographic Presence
12.4.7 Strategic initiatives
12.4.8 SWOT
12.5 Promedica International
12.5.1 Company overview
12.5.2 Financial Performance
12.5.3 Organization structure & Team Composition
12.5.4 Team Composition
12.5.5 Service Benchmarking
12.5.6 Geographic Presence
12.5.7 SWOT
12.6 WuXi AppTec, Inc.
12.6.1 Company overview
12.6.2 Financial performance
12.6.3 Organization structure & Team Composition
12.6.4 Team Composition
12.6.5 Service Benchmarking
12.6.6 Geographic Presence
12.6.7 Strategic initiatives
12.6.8 SWOT
12.7 Medpace
12.7.1 Company overview
12.7.2 Financial performance
12.7.3 Organization structure & Team Composition
12.7.4 Team Composition
12.7.5 Service Benchmarking
12.7.6 Geographic Presence
12.7.7 swot
12.8 Charles River Laboratories International, Inc.
12.8.1 Company overview
12.8.2 Financial performance
12.8.3 Organization structure & Team Composition
12.8.4 Team Composition
12.8.5 Service Benchmarking
12.8.6 Geographic Presence
12.8.7 Strategic initiatives
12.8.8 SWOT
12.9 ICON plc
12.9.1 Company overview
12.9.2 Financial performance
12.9.3 Organization structure & Team Composition
12.9.4 Team Composition
12.9.5 Service Benchmarking
12.9.6 Geographic Presence
12.9.7 Strategic initiatives
12.9.8 SWOT
12.10 Covance
12.10.1 Company overview
12.10.2 Financial performance
12.10.3 Organization structure & Team Composition
12.10.4 Team Composition
12.10.5 Service Benchmarking
12.10.6 Geographic Presence
12.10.7 Strategic initiatives
12.10.8 SWOT
12.11 PAREXEL International Corporation, Inc.
12.11.1 Company overview
12.11.2 Financial performance
12.11.3 Organization structure & Team Composition
12.11.4 Team Composition
12.11.5 Service Benchmarking
12.11.6 Geographic Presence
12.11.7 Strategic initiatives
12.11.8 SWOT
12.12 Freyr
12.12.1 Company overview
12.12.2 Organization structure & Team Composition
12.12.3 Team Composition
12.12.4 Service Benchmarking
12.12.5 Geographic Presence
12.12.6 Strategic initiatives
12.12.7 SWOT
LIST OF TABLES
Table 1 Global regulatory affairs market, by region, 2018 - 2030 (USD Million)
Table 2 Global regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 3 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 4 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 5 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 6 Regulatory affairs market, by Innov., 2018 - 2030 (USD Million)
Table 7 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 8 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 9 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 10 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 11 Regulatory affairs market, by Biosimilars, 2018 - 2030 (USD Million)
Table 12 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 13 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 14 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 15 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 16 Regulatory affairs market, by Product Product Stage, 2018 - 2030 (USD Million)
Table 17 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 18 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 19 Global regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 20 North America regulatory affairs market, by region, 2018 - 2030 (USD Million)
Table 21 North America regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 22 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 23 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 24 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 25 Regulatory affairs market, by Innov., 2018 - 2030 (USD Million)
Table 26 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 27 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 28 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 29 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 30 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 31 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 32 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 33 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 34 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 35 Regulatory affairs market, by Product Product Stage, 2018 - 2030 (USD Million)
Table 36 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 37 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 38 North America Regulatory Affairs Market, by End-use, 2018 - 2030 (USD Million)
Table 39 U.S. regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 40 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 41 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 42 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 43 Regulatory affairs market, by Innov., 2018 - 2030 (USD Million)
Table 44 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 45 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 46 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 47 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 48 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 49 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 50 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 51 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 52 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 53 Regulatory affairs market, by Product Product Stage, 2018 - 2030 (USD Million)
Table 54 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 55 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 56 U.S. Regulatory Affairs Market, by End-use, 2018 - 2030 (USD Million)
Table 57 Canada regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 58 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 59 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 60 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 61 Regulatory affairs market, by Innov., 2018 - 2030 (USD Million)
Table 62 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 63 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 64 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 65 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 66 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 67 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 68 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 69 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 70 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 71 Regulatory affairs market, by Product Product Stage, 2018 - 2030 (USD Million)
Table 72 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 73 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 74 Canada Regulatory Affairs Market, by End-use, 2018 - 2030 (USD Million)
Table 75 Europe regulatory affairs market, by region, 2018 - 2030 (USD Million)
Table 76 Europe regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 77 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 78 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 79 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 80 Regulatory affairs market, by Innov., 2018 - 2030 (USD Million)
Table 81 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 82 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 83 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 84 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 85 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 86 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 87 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 88 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 89 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 90 Regulatory affairs market, by Product Product Stage, 2018 - 2030 (USD Million)
Table 91 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 92 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 93 Europe regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 94 U.K. regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 95 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 96 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 97 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 98 Regulatory affairs market, by Innov., 2018 - 2030 (USD Million)
Table 99 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 100 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 101 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 102 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 103 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 104 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 105 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 106 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 107 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 108 Regulatory affairs market, by Product Product Stage, 2018 - 2030 (USD Million)
Table 109 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 110 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 111 U.K. regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 112 Germany regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 113 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 114 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 115 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 116 Regulatory affairs market, by Innov., 2018 - 2030 (USD Million)
Table 117 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 118 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 119 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 120 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 121 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 122 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 123 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 124 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 125 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 126 Regulatory affairs market, by Product Product Stage, 2018 - 2030 (USD Million)
Table 127 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 128 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 129 Germany regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 130 France regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 131 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 132 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 133 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 134 Regulatory affairs market, by Innov., 2018 - 2030 (USD Million)
Table 135 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 136 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 137 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 138 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 139 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 140 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 141 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 142 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 143 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 144 Regulatory affairs market, by Product Product Stage, 2018 - 2030 (USD Million)
Table 145 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 146 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 147 France regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 148 Italy regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 149 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 150 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 151 Regulatory affairs market, by Innov., 2018 - 2030 (USD Million)
Table 152 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 153 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 154 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 155 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 156 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 157 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 158 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 159 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 160 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 161 Regulatory affairs market, by Product Product Stage, 2018 - 2030 (USD Million)
Table 162 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 163 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 164 Italy regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 165 Spain regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 166 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 167 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 168 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 169 Regulatory affairs market, by Innov., 2018 - 2030 (USD Million)
Table 170 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 171 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 172 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 173 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 174 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 175 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 176 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 177 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 178 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 179 Regulatory affairs market, by Product Product Stage, 2018 - 2030 (USD Million)
Table 180 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 181 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 182 Spain regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 183 Russia regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 184 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 185 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 186 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 187 Regulatory affairs market, by Innov., 2018 - 2030 (USD Million)
Table 188 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 189 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 190 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 191 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 192 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 193 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 194 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 195 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 196 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 197 Regulatory affairs market, by Product Product Stage, 2018 - 2030 (USD Million)
Table 198 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 199 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 200 Russia regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 201 Turkey regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 202 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 203 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 204 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 205 Regulatory affairs market, by Innov., 2018 - 2030 (USD Million)
Table 206 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 207 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 208 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 209 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 210 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 211 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 212 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 213 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 214 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 215 Regulatory affairs market, by Product Product Stage, 2018 - 2030 (USD Million)
Table 216 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 217 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 218 Turkey regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 219 Netherlands regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 220 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 221 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 222 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 223 Regulatory affairs market, by Innov., 2018
Table 1 Global regulatory affairs market, by region, 2018 - 2030 (USD Million)
Table 2 Global regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 3 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 4 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 5 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 6 Regulatory affairs market, by Innov., 2018 - 2030 (USD Million)
Table 7 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 8 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 9 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 10 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 11 Regulatory affairs market, by Biosimilars, 2018 - 2030 (USD Million)
Table 12 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 13 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 14 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 15 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 16 Regulatory affairs market, by Product Product Stage, 2018 - 2030 (USD Million)
Table 17 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 18 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 19 Global regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 20 North America regulatory affairs market, by region, 2018 - 2030 (USD Million)
Table 21 North America regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 22 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 23 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 24 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 25 Regulatory affairs market, by Innov., 2018 - 2030 (USD Million)
Table 26 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 27 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 28 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 29 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 30 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 31 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 32 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 33 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 34 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 35 Regulatory affairs market, by Product Product Stage, 2018 - 2030 (USD Million)
Table 36 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 37 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 38 North America Regulatory Affairs Market, by End-use, 2018 - 2030 (USD Million)
Table 39 U.S. regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 40 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 41 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 42 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 43 Regulatory affairs market, by Innov., 2018 - 2030 (USD Million)
Table 44 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 45 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 46 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 47 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 48 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 49 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 50 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 51 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 52 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 53 Regulatory affairs market, by Product Product Stage, 2018 - 2030 (USD Million)
Table 54 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 55 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 56 U.S. Regulatory Affairs Market, by End-use, 2018 - 2030 (USD Million)
Table 57 Canada regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 58 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 59 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 60 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 61 Regulatory affairs market, by Innov., 2018 - 2030 (USD Million)
Table 62 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 63 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 64 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 65 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 66 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 67 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 68 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 69 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 70 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 71 Regulatory affairs market, by Product Product Stage, 2018 - 2030 (USD Million)
Table 72 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 73 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 74 Canada Regulatory Affairs Market, by End-use, 2018 - 2030 (USD Million)
Table 75 Europe regulatory affairs market, by region, 2018 - 2030 (USD Million)
Table 76 Europe regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 77 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 78 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 79 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 80 Regulatory affairs market, by Innov., 2018 - 2030 (USD Million)
Table 81 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 82 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 83 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 84 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 85 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 86 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 87 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 88 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 89 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 90 Regulatory affairs market, by Product Product Stage, 2018 - 2030 (USD Million)
Table 91 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 92 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 93 Europe regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 94 U.K. regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 95 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 96 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 97 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 98 Regulatory affairs market, by Innov., 2018 - 2030 (USD Million)
Table 99 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 100 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 101 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 102 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 103 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 104 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 105 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 106 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 107 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 108 Regulatory affairs market, by Product Product Stage, 2018 - 2030 (USD Million)
Table 109 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 110 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 111 U.K. regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 112 Germany regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 113 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 114 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 115 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 116 Regulatory affairs market, by Innov., 2018 - 2030 (USD Million)
Table 117 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 118 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 119 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 120 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 121 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 122 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 123 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 124 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 125 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 126 Regulatory affairs market, by Product Product Stage, 2018 - 2030 (USD Million)
Table 127 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 128 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 129 Germany regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 130 France regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 131 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 132 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 133 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 134 Regulatory affairs market, by Innov., 2018 - 2030 (USD Million)
Table 135 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 136 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 137 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 138 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 139 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 140 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 141 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 142 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 143 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 144 Regulatory affairs market, by Product Product Stage, 2018 - 2030 (USD Million)
Table 145 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 146 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 147 France regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 148 Italy regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 149 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 150 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 151 Regulatory affairs market, by Innov., 2018 - 2030 (USD Million)
Table 152 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 153 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 154 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 155 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 156 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 157 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 158 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 159 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 160 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 161 Regulatory affairs market, by Product Product Stage, 2018 - 2030 (USD Million)
Table 162 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 163 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 164 Italy regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 165 Spain regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 166 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 167 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 168 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 169 Regulatory affairs market, by Innov., 2018 - 2030 (USD Million)
Table 170 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 171 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 172 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 173 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 174 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 175 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 176 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 177 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 178 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 179 Regulatory affairs market, by Product Product Stage, 2018 - 2030 (USD Million)
Table 180 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 181 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 182 Spain regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 183 Russia regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 184 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 185 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 186 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 187 Regulatory affairs market, by Innov., 2018 - 2030 (USD Million)
Table 188 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 189 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 190 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 191 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 192 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 193 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 194 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 195 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 196 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 197 Regulatory affairs market, by Product Product Stage, 2018 - 2030 (USD Million)
Table 198 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 199 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 200 Russia regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 201 Turkey regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 202 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 203 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 204 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 205 Regulatory affairs market, by Innov., 2018 - 2030 (USD Million)
Table 206 Regulatory affairs market, by Generics, 2018 - 2030 (USD Million)
Table 207 Regulatory affairs market, by Biologics, 2018 - 2030 (USD Million)
Table 208 Regulatory affairs market, by Biotech, 2018 - 2030 (USD Million)
Table 209 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 210 Regulatory affairs market, by ATMP, 2018 - 2030 (USD Million)
Table 211 Regulatory affairs market, by Medical Devices, 2018 - 2030 (USD Million)
Table 212 Regulatory affairs market, by Diagnostics, 2018 - 2030 (USD Million)
Table 213 Regulatory affairs market, by Therapeutics, 2018 - 2030 (USD Million)
Table 214 Regulatory affairs market, by Indication, 2018 - 2030 (USD Million)
Table 215 Regulatory affairs market, by Product Product Stage, 2018 - 2030 (USD Million)
Table 216 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 217 Regulatory affairs market, by Service Provider, 2018 - 2030 (USD Million)
Table 218 Turkey regulatory affairs market, by end-use, 2018 - 2030 (USD Million)
Table 219 Netherlands regulatory affairs market, by service, 2018 - 2030 (USD Million)
Table 220 Regulatory affairs market, by Regulatory writing & publishing, 2018 - 2030 (USD Million)
Table 221 Regulatory affairs market, by Category, 2018 - 2030 (USD Million)
Table 222 Regulatory affairs market, by Drugs, 2018 - 2030 (USD Million)
Table 223 Regulatory affairs market, by Innov., 2018
